Research graph
References from Nanomedicines with triiodothyronine and their effects on neurological tissues. Local targets link to admitted publications; unresolved targets remain external evidence.
Insights into exosome transport through the blood–brain barrier and the potential therapeutic applications in brain diseases
10.3390/ph16040571 · 2023 · External reference
Response to fitzgerald et al. re: “Thyroid stimulating hormone and thyroid hormones (Triiodothyronine and Thyroxine): An American thyroid association-commissioned review of current clinical and laboratory status”
10.1089/thy.2024.0049 · 2024 · External reference
Thyroid hormones and the brain
10.1006/frne.2000.0208 · 2001 · External reference
The thyroid-brain interaction in thyroid disorders and mood disorders
10.1111/j.1365-2826.2008.01774.x · 2008 · External reference
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
10.1016/j.nano.2015.09.004 · 2016 · External reference
Thyroid hormone receptors in brain development and function
10.1038/ncpendmet0424 · 2007 · External reference
Nanoparticle crossing of blood–blood-brain barrier: A road to new therapeutic approaches to central nervous system diseases
10.2217/nnm-2018-0139 · 2018 · External reference
Thyroid gland and brain: Enigma of hashimoto's encephalopathy
10.1016/j.beem.2019.101364 · 2019 · External reference
Advances in nanocarrier-mediated delivery of chrysin: Enhancing solubility, bioavailability, and anticancer efficacy
2024 · External reference
Current strategies for brain drug delivery
10.7150/thno.21254 · 2018 · External reference
The thyroid axis and mood disorders: Overview and future prospects
1997 · External reference
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
10.1074/jbc.m300909200 · 2003 · External reference
Progress and perspectives on targeting nanoparticles for brain drug delivery
10.1016/j.apsb.2016.05.013 · 2016 · External reference
Global transcriptome analysis of primary cerebrocortical cells: Identification of genes regulated by triiodothyronine in specific cell types
2017 · External reference
Precision nanomedicine in neurodegenerative diseases
10.1021/nn501292z · 2014 · External reference
Comparative approaches to understanding thyroid hormone regulation of neurogenesis
10.1016/j.mce.2017.05.020 · 2017 · External reference
Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: Trends and advances
10.2174/1871524914666141030145948 · 2014 · External reference
Pathophysiological importance of thyroid hormone transporters
10.1210/en.2008-1518 · 2009 · External reference
Development of triiodothyronine polymeric nanoparticles for targeted delivery in the cardioprotection against ischemic insult
10.3390/biomedicines9111713 · 2021 · External reference
Thyrotropin-releasing hormone-loaded and chitosan-engineered polymeric nanoparticles: Towards effective delivery of neuropeptides
10.1166/jnn.2016.12431 · 2016 · External reference
Personalized nanomedicine for CNS diseases
10.1016/j.drudis.2017.11.010 · 2018 · External reference
Nanoparticulate systems for brain delivery of drugs
10.1016/s0169-409x(00)00122-8 · 2001 · External reference
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
10.1016/j.addr.2013.08.008 · 2014 · External reference
Neurodegenerative disorders management: State-of-the-art and prospects of nano-biotechnology
10.1080/07388551.2021.1993126 · 2022 · External reference
Personalized nanomedicine
10.1158/1078-0432.ccr-12-1414 · 2012 · External reference
Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood–brain barrier permeability
2025 · External reference
Nanoparticles for brain drug delivery
2013 · External reference
Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis
10.1172/jci70324 · 2014 · External reference
Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke
10.1007/s13346-012-0117-8 · 2013 · External reference
How precise are nanomedicines in overcoming the blood–brain barrier? A comprehensive review of the literature
10.2147/ijn.s442520 · 2024 · External reference
Review on thyroid disease
2023 · External reference
Thyroid hormone action: Astrocyte–neuron communication
10.3389/fendo.2014.00082 · 2014 · External reference
Thyroid hormone action 1994: The plot thickens
10.1530/eje.0.1300015 · 1994 · External reference
Drug transport across the blood–brain barrier
10.1038/jcbfm.2012.126 · 2012 · External reference
Enhancement of neuroprotective and anti-edema action in a mouse ischemic stroke model using T3 loaded nanoparticles
10.55940/medphar202463 · 2024 · External reference
Genetic variation in thyroid hormone pathway genes: Polymorphisms in the TSH receptor and the iodothyronine deiodinases
10.1530/eje.1.02279 · 2006 · External reference
Hypothyroidism and depression: A therapeutic challenge
10.1345/aph.10022 · 2000 · External reference
Thyroid hormone signaling and adult neurogenesis in mammals
10.3389/fendo.2014.00062 · 2014 · External reference
Factors and mechanisms of thyroid hormone activity in the brain: Possible role in recovery and protection
10.3390/biom14020198 · 2024 · External reference
Nanotech approaches to drug delivery and imaging
10.1016/s1359-6446(03)02903-9 · 2003 · External reference
Nanoparticle-mediated brain drug delivery: Overcoming–brain barrier to treat neurodegenerative diseases
10.1016/j.jconrel.2016.05.044 · 2016 · External reference
A decrease in thyroid function after ischemic stroke is related to stroke severity
10.1186/s13044-023-00160-w · 2023 · External reference
Nanoparticle-based technology approaches to the management of neurological disorders
10.3390/ijms21176070 · 2020 · External reference
Inorganic nano-drug delivery systems for crossing the blood–brain barrier: Advances and challenges
10.1016/j.ccr.2023.215344 · 2023 · External reference
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier
10.2174/0929867311320170006 · 2013 · External reference
Post-ischemic triiodothyronine treatment improves stroke outcome by stabilizing the blood-brain barrier
2023 · External reference
Minireview: Thyroid hormone transporters: The knowns and the unknowns
10.1210/me.2010-0095 · 2011 · External reference
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases
10.3389/fddev.2023.1247162 · 2023 · External reference
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
10.1186/s12951-024-02681-4 · 2024 · External reference
Polymeric nanoparticles for the drug delivery to the central nervous system
10.1517/17425247.5.2.155 · 2008 · External reference
Thyroid hormones and the brain
10.1006/frne.2000.0208 · ExternalCitation · doi-reference
Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke
10.1007/s13346-012-0117-8 · ExternalCitation · doi-reference
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
10.1016/j.addr.2013.08.008 · ExternalCitation · doi-reference
Progress and perspectives on targeting nanoparticles for brain drug delivery
10.1016/j.apsb.2016.05.013 · ExternalCitation · doi-reference
Thyroid gland and brain: Enigma of hashimoto's encephalopathy
10.1016/j.beem.2019.101364 · ExternalCitation · doi-reference
Inorganic nano-drug delivery systems for crossing the blood–brain barrier: Advances and challenges
10.1016/j.ccr.2023.215344 · ExternalCitation · doi-reference
Personalized nanomedicine for CNS diseases
10.1016/j.drudis.2017.11.010 · ExternalCitation · doi-reference
Nanoparticle-mediated brain drug delivery: Overcoming–brain barrier to treat neurodegenerative diseases
10.1016/j.jconrel.2016.05.044 · ExternalCitation · doi-reference
Comparative approaches to understanding thyroid hormone regulation of neurogenesis
10.1016/j.mce.2017.05.020 · ExternalCitation · doi-reference
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
10.1016/j.nano.2015.09.004 · ExternalCitation · doi-reference
Nanoparticulate systems for brain delivery of drugs
10.1016/s0169-409x(00)00122-8 · ExternalCitation · doi-reference
Nanotech approaches to drug delivery and imaging
10.1016/s1359-6446(03)02903-9 · ExternalCitation · doi-reference
Precision nanomedicine in neurodegenerative diseases
10.1021/nn501292z · ExternalCitation · doi-reference
Drug transport across the blood–brain barrier
10.1038/jcbfm.2012.126 · ExternalCitation · doi-reference
Thyroid hormone receptors in brain development and function
10.1038/ncpendmet0424 · ExternalCitation · doi-reference
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
10.1074/jbc.m300909200 · ExternalCitation · doi-reference
Neurodegenerative disorders management: State-of-the-art and prospects of nano-biotechnology
10.1080/07388551.2021.1993126 · ExternalCitation · doi-reference
Response to fitzgerald et al. re: “Thyroid stimulating hormone and thyroid hormones (Triiodothyronine and Thyroxine): An American thyroid association-commissioned review of current clinical and laboratory status”
10.1089/thy.2024.0049 · ExternalCitation · doi-reference
The thyroid-brain interaction in thyroid disorders and mood disorders
10.1111/j.1365-2826.2008.01774.x · ExternalCitation · doi-reference
Personalized nanomedicine
10.1158/1078-0432.ccr-12-1414 · ExternalCitation · doi-reference
Thyrotropin-releasing hormone-loaded and chitosan-engineered polymeric nanoparticles: Towards effective delivery of neuropeptides
10.1166/jnn.2016.12431 · ExternalCitation · doi-reference
Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis
10.1172/jci70324 · ExternalCitation · doi-reference
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
10.1186/s12951-024-02681-4 · ExternalCitation · doi-reference
A decrease in thyroid function after ischemic stroke is related to stroke severity
10.1186/s13044-023-00160-w · ExternalCitation · doi-reference
Pathophysiological importance of thyroid hormone transporters
10.1210/en.2008-1518 · ExternalCitation · doi-reference
Minireview: Thyroid hormone transporters: The knowns and the unknowns
10.1210/me.2010-0095 · ExternalCitation · doi-reference
Hypothyroidism and depression: A therapeutic challenge
10.1345/aph.10022 · ExternalCitation · doi-reference
Polymeric nanoparticles for the drug delivery to the central nervous system
10.1517/17425247.5.2.155 · ExternalCitation · doi-reference
Thyroid hormone action 1994: The plot thickens
10.1530/eje.0.1300015 · ExternalCitation · doi-reference
Genetic variation in thyroid hormone pathway genes: Polymorphisms in the TSH receptor and the iodothyronine deiodinases
10.1530/eje.1.02279 · ExternalCitation · doi-reference
How precise are nanomedicines in overcoming the blood–brain barrier? A comprehensive review of the literature
10.2147/ijn.s442520 · ExternalCitation · doi-reference
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier
10.2174/0929867311320170006 · ExternalCitation · doi-reference
Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: Trends and advances
10.2174/1871524914666141030145948 · ExternalCitation · doi-reference
Nanoparticle crossing of blood–blood-brain barrier: A road to new therapeutic approaches to central nervous system diseases
10.2217/nnm-2018-0139 · ExternalCitation · doi-reference
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases
10.3389/fddev.2023.1247162 · ExternalCitation · doi-reference
Thyroid hormone signaling and adult neurogenesis in mammals
10.3389/fendo.2014.00062 · ExternalCitation · doi-reference
Thyroid hormone action: Astrocyte–neuron communication
10.3389/fendo.2014.00082 · ExternalCitation · doi-reference
Factors and mechanisms of thyroid hormone activity in the brain: Possible role in recovery and protection
10.3390/biom14020198 · ExternalCitation · doi-reference
Development of triiodothyronine polymeric nanoparticles for targeted delivery in the cardioprotection against ischemic insult
10.3390/biomedicines9111713 · ExternalCitation · doi-reference
Nanoparticle-based technology approaches to the management of neurological disorders
10.3390/ijms21176070 · ExternalCitation · doi-reference
Insights into exosome transport through the blood–brain barrier and the potential therapeutic applications in brain diseases
10.3390/ph16040571 · ExternalCitation · doi-reference
Enhancement of neuroprotective and anti-edema action in a mouse ischemic stroke model using T3 loaded nanoparticles
10.55940/medphar202463 · ExternalCitation · doi-reference
Current strategies for brain drug delivery
10.7150/thno.21254 · ExternalCitation · doi-reference
